← Winnie Hsu

What podcasts say about Winnie Hsu

Every statement, with the speaker, the exact quote and the moment it was said.

What Winnie Hsu has said on podcasts

101 statements · 69 positive · 22 negative · 4 mixed · 6 neutral

  1. on SK HynixPositiveAug 20, 2026· Stock Movers

    SK Hynix management signals confidence in future company growth.

    “management is very confident in terms of of the future growth of the company”

    Listen at 1:27

    Open the episode · SK Hynix Up, Kuaishou Plunges, Sino Biopharmaceutical Up
  2. on SK HynixPositiveAug 20, 2026· Stock Movers

    SK Hynix management signals confidence in future company growth.

    “management is very confident in terms of the future growth of the company”

    Listen at 1:50

    Open the episode · SK Hynix Up, Kuaishou Plunges, Sino Biopharmaceutical Up
  3. on SK HynixPositiveAug 20, 2026· Stock Movers

    SK Hynix plans further cash returns for investors.

    “there is further cash returns that it's planning for its investors”

    Listen at 1:56

    Open the episode · SK Hynix Up, Kuaishou Plunges, Sino Biopharmaceutical Up
  4. on Kuaishou AI development costsNegativeAug 20, 2026· Stock Movers

    High AI-development costs are reducing Kuaishou’s income.

    “the high cost of developing AI, AI-centered business is really weighing on the company's income”

    Listen at 2:28

    Open the episode · SK Hynix Up, Kuaishou Plunges, Sino Biopharmaceutical Up
  5. on KuaishouNegativeAug 20, 2026· Stock Movers

    Kuaishou’s high AI development costs reduce company income.

    “the high cost of developing a centered business is really weighing on the company's income”

    Listen at 2:51

    Open the episode · SK Hynix Up, Kuaishou Plunges, Sino Biopharmaceutical Up
  6. on Moderna-Merck personalized melanoma vaccinePositiveAug 20, 2026· Stock Movers

    Moderna-Merck personalized vaccine reduces melanoma recurrence.

    “a personalized vaccine co developed by Moderna and Merck to reduce the recurrence of melanoma”

    Listen at 4:03

    Open the episode · SK Hynix Up, Kuaishou Plunges, Sino Biopharmaceutical Up
  7. on mRNA-based cancer therapyPositiveAug 20, 2026· Stock Movers

    The trial is the first positive late-stage trial for an mRNA cancer therapy.

    “this is the first time we are seeing a positive late stage trial for any mRNA based cancer therapy”

    Listen at 4:05

    Open the episode · SK Hynix Up, Kuaishou Plunges, Sino Biopharmaceutical Up
  8. on Moderna-Merck personalized melanoma vaccinePositiveAug 20, 2026· Stock Movers

    The personalized vaccine can be customized to patients’ tumor mutations.

    “they can customize the vaccines based on the patient's specific tumor mutations”

    Listen at 4:16

    Open the episode · SK Hynix Up, Kuaishou Plunges, Sino Biopharmaceutical Up
  9. on Moderna sharesPositiveAug 20, 2026· Stock Movers

    Moderna shares rose 177% after the late-stage trial news.

    “Moderna shares up 177% yesterday”

    Listen at 4:25

    Open the episode · SK Hynix Up, Kuaishou Plunges, Sino Biopharmaceutical Up
  10. on Moderna-Merck mRNA cancer therapy trialPositiveAug 20, 2026· Stock Movers

    The Moderna-Merck trial is the first positive late-stage mRNA cancer-therapy trial.

    “this is the first time we are seeing a positive late stage trial for any M RNA based cancer therapy”

    Listen at 4:28

    Open the episode · SK Hynix Up, Kuaishou Plunges, Sino Biopharmaceutical Up
  11. on SinobiopharmPositiveAug 20, 2026· Stock Movers

    Sino Biopharmaceutical shares rose more than 10%.

    “Sino Biopharmaceuticals, for example, up more than 10%”

    Listen at 4:35

    Open the episode · SK Hynix Up, Kuaishou Plunges, Sino Biopharmaceutical Up
  12. on Moderna-Merck personalized cancer vaccinePositiveAug 20, 2026· Stock Movers

    The vaccine can be customized to patients’ specific tumor mutations.

    “they can customize the vaccines based on the patient's specific tumor mutations”

    Listen at 4:39

    Open the episode · SK Hynix Up, Kuaishou Plunges, Sino Biopharmaceutical Up
  13. on Moderna-Merck personalized melanoma vaccineNeutralAug 20, 2026· Stock Movers

    The personalized vaccine requires approval, with a timeline extending to 2027 or later.

    “it has to... be approved for now we are looking at the timeline at 2027 plus”

    Listen at 4:45

    Open the episode · SK Hynix Up, Kuaishou Plunges, Sino Biopharmaceutical Up
  14. on Moderna-Merck personalized cancer vaccineNeutralAug 20, 2026· Stock Movers

    The personalized cancer vaccine still requires regulatory approval.

    “it has to be approved”

    Listen at 5:08

    Open the episode · SK Hynix Up, Kuaishou Plunges, Sino Biopharmaceutical Up
  15. on Moderna-Merck personalized cancer vaccineNeutralAug 20, 2026· Stock Movers

    The personalized cancer vaccine timeline extends to 2027 or later.

    “we are looking at the timeline at 2027 plus”

    Listen at 5:10

    Open the episode · SK Hynix Up, Kuaishou Plunges, Sino Biopharmaceutical Up
  16. on Unitree Robotics IPOPositiveAug 19, 2026· Stock Movers

    Unitree Robotics’ IPO may establish a global valuation anchor for humanoid robotics.

    “it sets potentially... the global valuation anchor of the whole humanoid space”

    Listen at 2:15

    Open the episode · Unitree Surges, Baidu Plummets, Xiaomi Rises
  17. on UnitreePositiveAug 19, 2026· Stock Movers

    Unitree Robotics became mainland China’s first publicly traded humanoid robot maker.

    “the company Unitree Robotics is now the very first publicly traded humanoid robot maker in mainland China”

    Listen at 2:17

    Open the episode · Unitree Surges, Baidu Plummets, Xiaomi Rises
  18. on Unitree IPO valuationPositiveAug 19, 2026· Stock Movers

    Unitree’s IPO may establish a global valuation benchmark for humanoid robotics.

    “it sets potentially the global valuation anchor of the whole humanoid space”

    Listen at 2:38

    Open the episode · Unitree Surges, Baidu Plummets, Xiaomi Rises
  19. on Chinese humanoid robotics marketPositiveAug 19, 2026· Stock Movers

    China’s market may represent about half of global humanoid robotics by 2030.

    “the Chinese market to take up about 50% of this whole humanoid robotics space by 2030”

    Listen at 2:56

    Open the episode · Unitree Surges, Baidu Plummets, Xiaomi Rises
  20. on Unitree humanoid robotsPositiveAug 19, 2026· Stock Movers

    Unitree’s humanoid robot may become more commercially viable over time.

    “we really want to see going forward how this dancing robot is actually going to become more commercially viable”

    Listen at 3:05

    Open the episode · Unitree Surges, Baidu Plummets, Xiaomi Rises
  21. on Baidu AI modelNegativeAug 19, 2026· Stock Movers

    Baidu’s model is inferior to rivals such as Moonshot AI.

    “Its model actually is not as good as the other open way. rivals, the likes of Moonshot AI, for example.”

    Listen at 3:34

    Open the episode · Unitree Surges, Baidu Plummets, Xiaomi Rises
  22. on BaiduNegativeAug 19, 2026· Stock Movers

    Baidu’s advertising business continues to struggle because of social-media and chatbot competition.

    “its core business in the advertisement business, which is usually quite high margin, continues to struggle because of the rivals from social media, but also these chat bots”

    Listen at 3:38

    Open the episode · Unitree Surges, Baidu Plummets, Xiaomi Rises
  23. on Baidu AI modelNegativeAug 19, 2026· Stock Movers

    Baidu’s AI model is inferior to open-weight rivals such as Moonshot AI.

    “Its model actually is not as good as the other open weight rivals, the likes of Moonshot AI for example”

    Listen at 3:57

    Open the episode · Unitree Surges, Baidu Plummets, Xiaomi Rises
  24. on BaiduNegativeAug 19, 2026· Stock Movers

    Baidu shares fell approximately 12%.

    “shares plummeting about 12% at this point”

    Listen at 4:20

    Open the episode · Unitree Surges, Baidu Plummets, Xiaomi Rises
  25. on XiaomiPositiveAug 19, 2026· Stock Movers

    Xiaomi’s smartphone business performed better than expected.

    “the smartphone business was also was able to perform better than expected”

    Listen at 4:55

    Open the episode · Unitree Surges, Baidu Plummets, Xiaomi Rises
  26. on XiaomiPositiveAug 19, 2026· Stock Movers

    Stabilizing memory-price increases may reduce pressure on Xiaomi and similar stocks.

    “there's going to be less pressure on these names going forward”

    Listen at 4:56

    Open the episode · Unitree Surges, Baidu Plummets, Xiaomi Rises
  27. on XiaomiPositiveAug 19, 2026· Stock Movers

    Stabilizing memory-chip prices may reduce pressure on Xiaomi and similar companies.

    “there's going to be less pressure on these names going forward”

    Listen at 5:19

    Open the episode · Unitree Surges, Baidu Plummets, Xiaomi Rises
  28. on Samsung and SK Hynix AI-driven cash flowsPositiveAug 12, 2026· Stock Movers

    AI demand is driving surging cash flows for Samsung and SK Hynix.

    “the focus is shifting towards the potential cash returns of these companies that have really. seen surging cash flows due to the AI demand and the profitability of the business.”

    Listen at 1:06

    Open the episode · Samsung Rallies, Tencent Slumps, Taiyo Yuden Rises
  29. on Samsung and SK Hynix shareholder-return plansPositiveAug 12, 2026· Stock Movers

    Samsung and SK Hynix are expected to announce massive shareholder-return plans later this month.

    “So expecting these two companies to announce these massive plans as early as later this month.”

    Listen at 1:33

    Open the episode · Samsung Rallies, Tencent Slumps, Taiyo Yuden Rises
  30. on Samsung and SK Hynix shareholder-return plansPositiveAug 12, 2026· Stock Movers

    Samsung and SK Hynix are expected to announce large shareholder-return plans later this month.

    “expecting these two companies to announce these massive plans as early as later this month”

    Listen at 1:56

    Open the episode · Samsung Rallies, Tencent Slumps, Taiyo Yuden Rises

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.